Why Profusa Stands Out in Small-Cap Investing Profusa (NASDAQ: PFSA) is a biotech company that is developing tissue‑integrating biosensors for…
Read More »Healthcare
Bitcoin (BTCUSD) climbed as high as $124,200 on August 14, touching another record high as investors embraced riskier assets amid…
Read More »Profusa (NASDAQ: PFSA) is ramping up its leadership team just as the company accelerates efforts to commercialize its groundbreaking biosensor…
Read More »Profusa (NASDAQ: PFSA) has been making waves in the red-hot wearable technology sector with its innovative Lumee™ Oxygen platform, expansion…
Read More »Profusa (NASDAQ: PFSA) is moving fast to cement its position in the rapidly expanding wearables industry, unveiling a five-pillar growth…
Read More »Profusa (NASDAQ: PFSA), a rising player in digital health, just made two bold moves that caught the attention of investors…
Read More »WealthyVC.com scans North America’s 10,000+ publicly listed stocks across all seven exchanges to find the market-moving news that matters. Our…
Read More »Markets sent a clear message Friday following President-elect Donald Trump’s nomination of Robert F. Kennedy Jr. to head the Department…
Read More »Therma Bright (TSXV: THRM) (OTCQB: TBRIF) (FSE: JNX), a developer and investment partner in a wide range of leading-edge, proprietary…
Read More »The ongoing US port strike on the East and Gulf coasts is causing significant disruptions to pharmaceutical supply chains, particularly…
Read More »









